• info@bpendo.org
  • (405)-974-0776

BPENDO

We are a new and trusted name in gastroenterology innovation

Colonoscopy is the golden standard for colon cancer screening, polyp removal, and control of lower gastrointestinal bleeding. The ability of the patient to hold air or fluid to insufflate the colon is critical to a successful colonoscopy. However, based on surveys completed by gastroenterologists, air or fluid incontinence occurs 20% of the time. This makes it not only difficult for the physician to complete an exam, but it puts the patient’s safety and overall health at risk. The IRD device was designed to improve the colonoscopy experience for patients, physicians, & payors. 

Patents: US 10,918,815 B2 | US 11,273,269 B2 | FDA 510(k) cleared
Patents: US 10,918,815 B2 | US 11,273,269 B2 | FDA 510(k) cleared

LEADERSHIP

Combining a team of gastroenterologists with experienced life science executives to create a new innovative medical device.

Robert Holbrook, MD

Founder and CEO

Dr. Holbrook is a gastroenterologist in Norman and has been in practice for a little over 12 years. In that time, he has done over 15,000 colonoscopies, as well has having participated as an investigator or Sub-I in over 30 clinical trials developing new medicines for market. Combining his professional experience with the experience of owning his own practice, Dr. Holbrook brings in depth industry knowledge to BPEndo.

ADVISORS

Mickey Young, JD, MD

Intellectual property Attorney

Dr. Young earned his MD at the Boston University school of Medicine & received his JD from Creighton University School of Law. He is a  U.S. patent attorney with experience practicing in the medical device industry.

Charles Lackey, MD

Dr. Lackey is a board-certified gastroenterologist who has performed over 20,000 colonoscopies in his career.

STRATEGIC PARTNERS

Based in Oklahoma City, OK and Tulsa, Oklahoma, i2E is nationally recognized for their business expertise and funding services they provide for Oklahoma’s emerging small businesses. I2E has nearly $50 million of investment capital under management in the region.

OU Med is the premiere enterprise for advancing healthcare, medical education, and research for the community, state, and region.

EG-Gilero is our partner for the design, development, and manufacturing of the IRD device. With over 100 issued patents for medical devices. EG-Gilero is used by some of the largetst names in healthcare Ie: Johnson & Johnson, Pfizer, Medtronic, & Bayer.

Aptyx is a leading manufacturer for complex injection molding, extrusion, coating, and medical device assembly.